The ability of an improved polymerase chain reaction (PCR) protocol to detect Eperythrozoon suis DNA in the blood of experimentally infected nonsplenectomized pigs was evaluated. The protocol utilizes previously described E. suis-specific primers and a proprietary DNA-releasing reagent in a 2-step amplification cycle followed by visualization of the 492-bp amplification product on agarose gels. This PCR protocol successfully amplified E. suis DNA in blood from all postinfection samples and from the preinfection samples of 2 pigs, indicating preexisting natural infections. Results of the indirect hemagglutination test on serum samples from these pigs revealed that only 1 pig developed detectable antibody titers to E. suis infection during the 43day study; that pig was determined by PCR to have been infected naturally with E. suis prior to experimental inoculation. These results confirm previous reports of poor antibody response of young pigs to E. suis infection and demonstrate the potential of PCR as a valuable tool for the diagnosis and study of E. suis infection in pigs.
with 6 ml of E. suis-infected whole pig blood. They were splenectomized on postinfection (PI) day 31. The pigs were monitored daily (rectal temperature, attitude, appetite), and whole blood samples for PCR and blood smear analysis were taken preinfection and on PI days 3, 5, 7, 10, 11, 13, 14, 16, 18, 26, 31, 38, and 42 or until the pig died or was euthanized. Serum samples for IHA were obtained on PI days 3, 5, 7, 13, 16, 26, 31, and 38. Blood samples. Uninfected (negative) control blood samples were collected from specific-pathogen-free (SPF) pigs that were shown to be E. suis negative by blood smears and IHA. Because of the possibility that the SPF pigs might be infected latently with E. suis, blood from clinically healthy cats also was utilized as a negative control.
Whole blood samples for PCR were collected in vacuum tubes containing ethylenediaminetetraacetic acid (EDTA). Wright's-stained blood smears were made from a small amount of the whole blood, and the remainder was stored at -70 C. Blood smears were evaluated using light microscopy for the presence of E. suis organisms. Serum was harvested from blood samples collected in siliconized vacuum tubes and stored at -70 C. All serum samples were submitted to an independent diagnostic laboratory a for evaluation of titers to E. suis using the IHA.
Preparation of blood samples for PCR amplification. Extraction of DNA from blood samples was accomplished using a commercially available DNA releasing reagent (GR) b according to the manufacturer's recommendations. Five microliters of whole blood was combined with 15 µl of GR in a 500-µl thin-walled microtube. c The mixtures were denatured using an automated DNA thermal cycler d (65 C for 15 sec, 8 C for 15 sec, 65 C for 30 sec, 97 C for 45 sec, 8 C for 15 sec, 65 C for 45 sec, 97 C for 15 sec, 65 C for 15 sec, 80 C for 1 min).
Primers. Primers used for the enzymatic amplification of E. suis DNA were synthesized based on sequence analysis of an E. suis-specific DNA probe. 8 The primer sequences were 5'-TCTTCAACTCTTCCTATGGA-3' (P 5 ) and 5'- Results of indirect hemagglutination assay of serum from pig C2 following inoculation with E. suis. The rise in titer following E. suis inoculation is typical of an anamnestic antibody response, indicating prior exposure to E. suis. The titer subsequently declined and became negative by PI day 31.
CTCATGGTAAGTTGTGTTGC-3' (P R252 ) and were designed to yield a 492-bp DNA fragment when used in PCRs containing E. suis DNA. The primers were stored at -20 C in Tris-EDTA buffer to give a final concentration of approximately 20 mM.
PCR. Reaction mixtures of 100 µl, containing 20 µl of the GR mixture or 10 µl of resuspended DNA extracted from whole blood, were amplified in PCRs using an automated DNA thermal cycler. d PCR reagents were used according to the manufacturer's recommendations. e Reaction mixtures contained 10 mM Tris-HC1 (pH 8.3), 50 mM KCl, 200 µM each of the four deoxynucleoside triphosphates, 1 µM of each E. suis-specific primer, 2.5 mM MgCl 2 , and 2.5 units of Taq DNA polymerase. One nanogram of KSU-2 DNA in 10 µl sterile water was used as the positive control DNA template.
Reaction mixtures were denatured (95 C for 15 sec) then incubated in a single anneal-extension step (60 C for 1 min) that was repeated 35 times. Following the last cycle, a final incubation (60 C for 5 min) was performed, and the mixtures were stored at 4 C.
Amplification products (25 µl/sample) were electrophoresed on 1% agarose gels at 100 V for 45 min. The gels were stained with ethidium bromide, and amplification products were visualized by ultraviolet illumination.
Results
Experimental pigs. All pigs remained clinically healthy (normal rectal temperatures and appetites) with no detectable E. suis parasitemia until splenectomy on PI day 31. Red blood cells infected with E. suis were detected by light microscopy 3-8 days postsplenectomy (PI days 34-39). Following splenectomy, the pigs developed clinical eperythrozoonosis and died within a period of 12 days. Pigs C1, C2, and C3 died on PI days 41, 38, and 42, respectively. Pig C4 was moribund and euthanized on PI day 43.
Indirect hemagglutination results. All 4 pigs lacked detectable IHA antibody titers on PI day 0 (day of infection). Pigs C1, C3, and C4 failed to develop detectable IHA titers to E. suis infection throughout the study. Pig C2 developed a 1:40 titer on PI days 3 and 5, a titer considered suspect by the testing laboratory. On PI day 7, the titer was 1:80, which was interpreted as positive. The titer declined to 1:40 on PI days 13, 16 , and 26 and was subsequently negative throughout the remainder of the study (Fig. 1 ).
PCR. Results of agarose gel electrophoresis of PCR
amplification products from all pigs using GR-extracted DNA are shown in Fig. 2 . When PCR was performed on preinfection (day 0) blood samples from pigs C2 and C3, an approximately 500-bp amplification product was obtained. Amplification of these preinfection samples was repeated for each pig with the same results. Subsequent blood samples from these 2 pigs consistently yielded amplification product for the remainder of the study. Blood from pigs Cl and C4 showed no amplification product on day 0; however, PCR performed on samples taken on subsequent days consistently resulted in an approximately 500-bp amplification product. No amplification product was obtained from blood of negative control animals (SPF pigs and cats).
Discussion
This study demonstrated the ability of an improved PCR protocol to detect latent E. suis infection in nonsplenectomized experimentally infected pigs. Amplification of E. suis DNA was successful on all PI days in all 4 pigs. In 2 pigs (C2 and C3), amplification of E. suis DNA occurred in preinfection blood samples, indicating that these pigs had been infected naturally prior to being obtained for this study. This result is similar to that of a previous study in which 1 of 3 splenectomized pigs was infected latently prior to experimental inoculation with E. suis organisms. 3 In each study, all pigs were obtained from local livestock sales and were negative for E. suis infection by routine screening tests (blood smear analysis and/or IHA) performed prior to the start of the study.
The interactions between E. suis and the red blood cell (RBC) membrane are important features of the pathogenicity of E. suis infection. 13 Depressions formed on RBC membranes by attachment of E. suis organisms cause permanent alterations in the RBC cytoskeleton. Deformed RBCs subsequently are opsonized by immunoglobulin M (IGM) cold agglutinins, 5 which facilitates their removal from the circulation. Predictably, IgM levels are high during times of active parasitemia and low to absent during times of low parasitemia (e.g., during chronic or latent infections). The IgM cold agglutinins appear to be directed primarily against membrane antigens exposed by E. suis-induced injury rather than against the E. suis organism itself. 5 The exact mechanism of RBC antigenic alteration caused by E. suis attachment is unknown but may include exposure of parasite-RBC antigenic complexes, exposure of hidden RBC antigens, or modification of existing membrane antigens. 14 The IHA is used currently for detection of IgM antibodies developed during E. suis infection. Because of the nature of the antibody response in E. suis-infected pigs, the IHA has limited usefulness in diagnosis of eperythrozoonosis. 5, 9, 14 Pigs tested during periods of low parasitemia (such as occurs in latent or chronic infections) may have few detectable circulating IgM antibodies and may therefore test negative. 9 Because titers in individual infected pigs fluctuate, a positive diagnosis from a single test is less likely. Antibody responses in different age groups of pigs also vary; sows tend to have more positive titers than boars, and infected pigs <3 months of age frequently have no detectable titers. 9 Eperythrozoon suis also suppresses T-cell function, which may indirectly inhibit effective humoral responses by decreasing T-helper functions, resulting in diminished B-cell stimulation and antibody production. 14 Subsequent decreases in all immunoglobulins classes, including IgM, could result in false-negative IHA titers. Lack of sufficient time for an adequate antibody response to occur following infection also may result in false-negative IHA titers.
During the course of this study, only pig C2 developed IHA-detectable antibody titers to E. suis (Fig. 1,  2 ). Although this pig had no preinfection titer to E. suis, a 1:40 (suspect) titer developed by PI day 3. This titer peaked at 190 (considered positive) on PI day 7, declined to 1:40 on PI days 13, 16, and 26, and was negative thereafter. This response is typical of a secondary (anamnestic) immune response to an antigen 0 and indicates prior exposure to E. suis antigen. The antibody response in this pig was consistent with the results of the PCR, which showed that the animal was latently infected with E. suis prior to experimental inoculation. The production of IgM has been reported to increase as E. suis-infected pigs become parasitemic; 12 however, none of the pigs, including C2, developed detectable IHA titers while parasitemic. These results help to confirm reports that pigs <3 months of age have poor antibody responses to E. suis infection. 9 They also demonstrate the limited usefulness of the IHA in diagnosing individual E. suis infection in latently infected animals because of the high incidence of false negatives. C3 (c), and C4 (d) . Day PI indicates the date the samples were taken following inoculation with E. suis; Day 0 = a pre-inoculation sample; and + and -= positive and negative control samples, respectively. For IHA titers, -= < 1:40; ± = 1:40 (suspect); + = 1:80; ND = no serum samples were tested for that day. For PCR results, the presence of a band on the ethidium bromide-stained gel indicates that E. suis DNA was present in the blood sample, indicating infection with E. suis. Presence or absence of PCR amplification products from all pigs was further confirmed by DNA hybridizations using a specific DNA probe (data not shown). Note that blood from pigs C2 and C3 yielded amplification products on day 0, indicating preexisting infection.
A recently developed enzyme-linked immunosorbent assay (ELISA) reportedly has greater sensitivity and specificity than the IHA and could be adapted easily to large-scale use. 6 The test utilizes an antibody that is specific for heavy and light immunoglobulin chains and, therefore, is theoretically capable of detecting any class of immunoglobulin. Initial reports indicate an ELISA seropositive rate of 87.7% (compared with 80.7% with the IHA) in serum samples from splenectomized parasitemic pigs experimentally in-fected with E. suis. Although this test appears to have improved sensitivity as compared with the IHA, it shares with the IHA the disadvantage inherent in tests that rely on the detection of antibody, i.e., false negatives due to poor antibody responses, etc. This disadvantage also may limit the usefulness of the ELISA in detecting latent infection in pigs. Additionally, the specificity of the ELISA is still in question because the antigen preparations used in the development of the test contained lysed RBCs. Studies have not determined yet whether the ELISA detects antibodies directed against the lysed RBC membranes within the antigen preparation or against the E. suis organism itself.
In contrast to tests measuring antibody responses to infectious agents, PCR directly amplifies DNA contained within infectious organisms, thus allowing direct detection of the organism within host tissues. 1 Depending on the primers selected, PCR can be used to distinguish among different species or even among different strains within a species. This high degree of specificity is a key reason for the increased use of PCR in the diagnosis of infectious disease. 1 The primers used for the PCR amplification of E. suis DNA were selected from a DNA probe that had been shown previously to be specific for E. suis. 4, 8 The current PCR protocol is more efficient and appears to be more sensitive than previously published PCR protocols. 3, 7 With use of the DNA-releasing agent, GR, samples are ready for amplification within 15 minutes, as compared with a minimum of 3 hours with the previous technique. Modification of the PCR temperature cycling program to a 2-step cycle that is completed in less than half of the time of the original program results in more efficient amplification of E. suis DNA. These improvements have shortened the time for obtaining and detecting PCR amplification products to less than 4 hours. Increased sensitivity was demonstrated by comparing the previously reported protocol with the improved protocol using identical blood samples (data not shown); the improved protocol yielded increased amounts of amplification product yet used 10% of the amount of whole blood. 2 Although initially developed as a research tool, PCR has been adapted for use as a powerful diagnostic tool through the development of nonisotopic assays, 11 such as the enzyme-linked oligonucleotide sandwich assay, which permit highly sensitive detection of PCR amplification products without the need for agarose gels. Amplification products are detected by calorimetric analysis, often using microtiter plates. These nonisotopic assays have sensitivities and specificities comparable to DNA hybridizations. 11 The PCR protocol described could be adapted to 1 of these methods, resulting in an efficient diagnostic test.
This study demonstrated the sensitive detection of latent (natural) and experimental E. suis infection in nonsplenectomized pigs using PCR. The PCR protocol contains several improvements over the previously reported protocol in regards to sensitivity and efficiency. With further adaptation of detection methodology, the PCR protocol described here could be used as a sensitive assay for both acute and chronic E. suis infections in pigs.
